Morning Overview on MSN

In January 2026, the FDA told drugmakers to strip suicide-warning language from Wegovy, Zepbound and Saxenda labels

Federal drug regulators concluded that three obesity medicines should no longer carry label language warning about suicidal ...

FDA's 2026 testosterone replacement therapy label overhaul seeks to remove age-related restriction

"FDA's responsibility is to ensure prescribing information reflects the best available scientific evidence." ...

Inside the FDA’s Push to Update Testosterone Therapy Labels on Prostate Cancer and Blood Pressure

Federal regulators are moving to rewrite the rulebook on testosterone replacement therapy, easing warnings that have shaped how doctors prescribe the hormone for more than a decade. The shift, driven ...
Medical Xpress

FDA requires stronger safety labels for opioid medications

The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain medications to better highlight the risks of long-term use, including misuse, ...
Medical Xpress

Research: FDA drug labels not proof of patent violation

Federal law requires every prescription drug to include a document describing dosing guidelines, contraindications, results from clinical trials and safety considerations. But a spate of recent court ...